10.6084/m9.figshare.12206147.v1
Lu Wang
Lu
Wang
Yujing Di
Yujing
Di
Tingting Guo
Tingting
Guo
Jeffrey E. Ming
Jeffrey E.
Ming
Fangyuan Kong
Fangyuan
Kong
Huiqiu Yin
Huiqiu
Yin
Linlin Zhang
Linlin
Zhang
Fang Xie
Fang
Xie
Na Yang
Na
Yang
Chuan Ping
Chuan
Ping
Yi Li
Yi
Li
Jie Hou
Jie
Hou
Implementation of a Reference-Scaled Average Bioequivalence Approach for Highly Variable Acetylsalicylic Acid in Fixed-Dose Combination With Clopidogrel Versus Enteric Aspirin in Chinese Subjects Under Fasting Conditions: A Phase 1, Open-Label, Randomized, Crossover Study
Adis Journals
2020
Acetylsalicylic acid
Bioequivalence
Clopidogrel
Co-Plavix
Fixed dose combination
RSABE
2020-05-14 09:46:37
Media
https://adisjournals.figshare.com/articles/media/Implementation_of_a_Reference-Scaled_Average_Bioequivalence_Approach_for_Highly_Variable_Acetylsalicylic_Acid_in_Fixed-Dose_Combination_With_Clopidogrel_Versus_Enteric_Aspirin_in_Chinese_Subjects_Under_Fasting_Conditions_A_Phase_1_Open-Labe/12206147
<p>The above summary slide represents
the opinions of the authors. For a full list of declarations, including funding
and author disclosure statements, please see the full text online (see “read
the peer-reviewed publication” opposite).<br></p>
<p>© The authors, CC-BY-NC 2020.</p>
<p> </p>